Supernus Pharmaceuticals
SUPN
HK$259.98
Share price
-0.06%
Change (1 day)
16.88%
Change (1 year)
Categories
Supernus Pharmaceuticals (SUPN) - Total debt
Total debt on the balance sheet as of March 2025 : HK$0.25 Billion
According to Supernus Pharmaceuticals 's latest financial reports the company's total debt is HK$0.25 Billion. A company’s total debt is the sum of all current and non-current debts.
Supernus Pharmaceuticals - Total debt on balance sheet (from 2009 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | HK$0.26 B | -17.96% |
| 2023-12-31 | HK$0.32 B | -90.67% |
| 2022-12-31 | HK$3.47 B | 4.36% |
| 2021-12-31 | HK$3.32 B | 3.67% |
| 2020-12-31 | HK$3.21 B | 8.98% |
| 2019-12-31 | HK$2.94 B | 14.24% |
| 2018-12-31 | HK$2.57 B | |
| 2017-12-31 | N/A | -100% |
| 2016-12-31 | HK$32.29 M | -41.18% |
| 2015-12-31 | HK$54.91 M | -73% |
| 2014-12-31 | HK$0.20 B | -23.73% |
| 2013-12-31 | HK$0.26 B | 50.27% |
| 2012-12-31 | HK$0.17 B | -22.5% |
| 2011-12-31 | HK$0.22 B | -60.76% |
| 2010-12-31 | HK$0.58 B | 0.37% |
| 2009-12-31 | HK$0.58 B | 0.34% |
| 2008-12-31 | HK$0.57 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Zogenix ZGNX | N/A | N/A | 🇺🇸 USA |
 United Therapeutics UTHR | HK$1.56 B | 519.10% | 🇺🇸 USA |
 Eli Lilly LLY | HK$302.33 B | 119,125.82% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | HK$402.21 B | 158,510.12% | 🇺🇸 USA |
 Abbott Laboratories ABT | HK$103.94 B | 40,890.56% | 🇺🇸 USA |
 Johnson & Johnson JNJ | HK$410.16 B | 161,645.86% | 🇺🇸 USA |